Dec 2011

Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness

Antimicrob Agents Chemother

by Kaiser M, Bray MA, Cal M, Bourdin Trunz B, Torreele E, and Brun R. Antimicrob Agents Chemother, Dec 2011, 55(12):5602-8. doi: 10.1128/AAC.00246-11. Epub 2011 Sep 12.

Click here to read the article

Latest scientific articles

Stay connected

Get our latest news, personal stories, research articles, and job opportunities.

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness

Latest scientific articles

New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial

Performance evaluation of rapid diagnostic tests for Chagas disease in Jutiapa, Guatemala

Mass balance, pharmacokinetics, metabolism, and excretion of radiolabeled acoziborole, a potential novel treatment for human African trypanosomiasis, following single microtracer oral dose to humans

Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trials

Stay connected

Learn more

Get in touch

Support us

Work with us